34 results on '"Tollefson G"'
Search Results
2. VIVA (VIsualization of VAriants): A VCF File Visualization Tool
3. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders
4. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial
5. A Canadian customer survey to assess power system reliability worth
6. A Canadian Cost Of Interruption Study.
7. Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder.
8. Industrial and university test research collaboration.
9. A novel augmentation strategy for treating resistant major depression.
10. Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression.
11. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms.
12. Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.
13. Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group.
14. Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy.
15. Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol.
16. Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group.
17. Olanzapine versus haloperidol treatment in first-episode psychosis.
18. Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses.
19. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group.
20. Consulting end-users on infrastructure worth.
21. Comorbid anxious signs and symptoms in major depression.
22. How long to onset of antidepressant action.
23. Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine.
24. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.
25. A double-blind trial of fluoxetine, 20 mg, and placebo in out-patients with DSM-III-R major depression and melancholia.
26. Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy.
27. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
28. Comprehensive bibliography on reliability worth and electrical service consumer interruption costs: 1980-90.
29. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
30. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
31. Alprazolam plus buspirone in treatment of anxiety.
32. Olanzapine reduces mania more effectively than divalproex, but has more adverse effects.
33. The central cholinergic system profile of olanzapine compared with placebo in Alzheimer's disease.
34. Assessment of electric service reliability worth
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.